期刊文献+

二维高效液相色谱法检测达托霉素血药浓度的可行性考察 被引量:1

A feasibility study to evaluate the use of 2D-HPLC for measuring the blood concentration of daptomycin
原文传递
导出
摘要 目的:建立二维高效液相色谱结合中间柱拦截技术测定达托霉素血药浓度的方法。方法:样品通过一维色谱柱Aston SRC(4.6 mm×50 mm,5μm)初步分离后,被中间柱ASTON-PLI(20 mm×4.6 mm,3μm)截取到二维色谱柱Aston SCB(4.6 mm×250 mm,5μm)进行二次分离;一维流动相为LC1移动相,流速:0.6 mL·min^(-1)。二维流动相为LC2移动相,流速:1.2 mL·min^(-1),检测波长260 nm,温度40°C,进样量200μL。结果:达托霉素在1.00~40.06μg·mL^(-1)范围内线性关系良好,r=0.9999,最低检测限为0.03μg·mL^(-1),绝对回收率为99.2%~101.9%,日间、日内RSD均小于5.94%。结论:该方法新颖,自动化程度高,样本检测简单快速、准确稳定,适用于临床达托霉素血药浓度的测定。 OBJECTIVE To establish method for the determination of the plasma concentration of daptomycin by using twodi⁃mensional high-performance liquid chromatography coupled with intermediate column interception.METHODS The analytes were preliminarily separated in the first-dimensional chromatographic column Aston SRC(4.6 mm×50 mm,5μm),intercepted by the intermediate column Aston PLI(20 mm×4.6 mm,3μm),and transferred to the second dimensional chromatographic col⁃umn Aston SCB(4.6 mm×150 mm,5μm)for further separation.The first-dimensional mobile phase was LC1 mobile phase at a flow rate of 0.6 mL·min^(-1).The second-dimensionmobile phase was LC2 mobile phase at a flow rate of 1.2 mL·min^(-1).The plasma samples were detected at a wavelength of 260 nm and a temperature of 40℃,with an injection volume of 200μL.RESULTS The linearity of daptomycin was good in the range of 1.00~40.06μg·mL^(-1)(r=0.9999).The lowest detection limit was 0.03μg·mL^(-1),the absolute recovery was 99.2%~101.9%,and the intra-day and inter-day RSD were less than 5.94%.CONCLUSION This novel method is automaticand simple,with high efficiency as well as accurate and stable perfor⁃mance,which is suitable for determining the clinical plasma concentration of daptomycin.
作者 肖俊辉 周玉生 李卓 吴广 XIAO Junhui;ZHOU Yusheng;LI Zhuo;Wu Guang(The Second Affiliated Hospital,Department of Pharacy,Hengyang Medical School,University of South China,Hunan Hengyang 421001,China;The Affiliated Nanhua Hospi-tal,Department of Pharmacy,Hengyang Medical School,University of South China,Hunan Hengyang 421001,China;The First Affiliated Hospital,Department of Pharmacy,Hengyang Medical School,University of South China,Hunan Hengyang 421001,China)
出处 《中国医院药学杂志》 CAS 北大核心 2024年第2期191-194,共4页 Chinese Journal of Hospital Pharmacy
基金 湖南省“科药联合基金”资助项目(编号:2021JJ80071)。
关键词 二维高效液相色谱法 达托霉素 血药浓度 two-dimensional high performance liquid chromatography daptomycin plasma concentration
  • 相关文献

参考文献9

二级参考文献74

  • 1柳文媛,徐维露,李萍,冯锋,丁黎.LC-MS/MS法研究黄芩素及其主要代谢物在大鼠体内的组织分布与排泄[J].中国药科大学学报,2009,40(4):348-352. 被引量:8
  • 2卜一珊,崔蓉.新的抗革兰阳性菌药物-达托霉素[J].中国药师,2005,8(7):594-596. 被引量:4
  • 3黄钦,魏春敏.浅谈高变异药物的生物等效性研究[J].中国临床药理学与治疗学,2007,12(8):841-844. 被引量:15
  • 4刘伯宁,石磊,蒋沁.环脂肽类抗生素研究进展[J].中国抗生素杂志,2007,32(9):520-524. 被引量:21
  • 5Tally FP, Zeckel M, Wasilewski MM. Daptomycin: a novel agent for grampositiveinfections [ J]. Expert Opin Investig Drugs, 1999, 8(8) :1223 - 1238.
  • 6Reyes J, Panesso D, Tran TT, et al. A liar deletion restores sus-ceptibility to daptomycin and antimicrobial peptides in multidrug- resistant Enterococcus faecalis [ J]. Infect Dis, 2015,211 ( 8 ) : 1317 - 1325.
  • 7Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis cam- paign: international guidelines for management of severe sepsis and septic shock, 2012 [J]. Intensive Care Med, 2013,39 ( 2 ) : 165 - 228.
  • 8Trotman RL, Williamson JC, Shoemaker DM, et al. Antibiotic dosing in critically Ill adult patients receiving continuous renal replacement therapy [ J ]. Clin Infect Dis, 2005,41 ( 8 ) : 1159 - 1566.
  • 9Dvorchik B, Moderate liver impairment has no influence on dap- tomycin pharmacokinetics [ J ]. Clin Pharmacol, 2004,44 ( 7 ) : 715 -722.
  • 10Tobin CM, Darville JM, Lovering AM, et al. An HPLC assay for daptomycin in serum [ J]. Antimicrob Chemother,2008,62 : 1462 - 1476.

共引文献27

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部